More recently, in January 2025, a press release was published detailing Vectura Fertin Pharma’s (VFP), a subsidiary of Philip Morris International, joint venture with a Canadian biotech firm focusing on cannabinoid-based drugs – Avicanna. According to the press release, the joint venture seeks to promote cannabis accessibility and research. Avicanna already has a stronghold in the wellness sector. However, the press release hardly makes any other mention about the involvement of Philip Morris International, but it’s clear that Big Tobacco has long had their eye in the cannabis industry.
Michigan’s cannabis market is buzzing with excitement as we enter February 2025. Whether you’re searching…
California’s cannabis scene is thriving this February 2025, and we’re here to spotlight the best…
2025 is underway, Leafly nation! February is a month for momentum and risk, and we…
Advocacy groups are closely monitoring legislative developments and public sentiment, identifying specific states that are…
The researchers then analyzed the mood and emotional regulation capabilities of the participants during times…
The cannabis industry presents an array of high-paying job opportunities across various sectors—from finance and…